Delivery Order SPE2DB22D2009-SPE2DB23FM3SB

Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $19K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $5,742.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562336205 doses of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over a one day period from September 28 through 29, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will deliver the vaccine in support of the Defense Logistics Agency's stockpile of critical medical countermeasures. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $35,077.90 to Amerisourcebergen Drug Corporation for 4561769603 doses of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 10th to August 11th, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,545.40 to Amerisourcebergen Drug Corporation for 1 vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will deliver the vaccine in support of the Defense Logistics Agency's stockpile of critical medical countermeasures. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,928.65 to Amerisourcebergen Drug Corporation for 4561781244 doses of MENVEO vaccine. Performance will occur in Conshohocken, Pennsylvania over a period of 3 days from August 11th through the 14th of 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will deliver the vaccines with no subcontractors. The Defense Logistics Agency procures medical supplies and...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,635.16 to Amerisourcebergen Drug Corporation for 1 vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in late August 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. No subcontractors or set aside designations were indicated. This order is...
The Defense Logistics Agency awarded a delivery order valued at $5,065.54 to Amerisourcebergen Drug Corporation for 1 vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The firm fixed price contract supports DLA's stockpile of vaccines and immunizations for military personnel. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,127 to Amerisourcebergen Drug Corporation for one vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the vaccine in support of the Defense Logistics Agency's medical countermeasures program. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,405 to Amerisourcebergen Drug Corporation for one vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor to supply the vaccine in support of the Defense Logistics Agency's medical countermeasures...
The Defense Logistics Agency awarded a $5,563.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in late August 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the vaccine in support of the Defense Logistics Agency's medical countermeasures procurement programs. No subcontractors or set aside designations were identified.
<p>The Defense Logistics Agency awarded a $29,616 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 vial of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over one day in late August 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the vaccine in support of the DLA's medical countermeasures procurement programs. No subcontractors or set aside designations were identified.</p>
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB23FM3SB
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,954.24 to Amerisourcebergen Drug Corporation for 4561993605 doses of MENVEO, a meningococcal vaccine. Performance will take place in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will deliver the vaccines in support of the Defense Logistics Agency's stockpile of critical medical countermeasures. No subcontractors or set aside designations were identified in the award information.

Generated 12/21/23, 11:55 PM